US Department of Justice Officially Confirms Marijuana is Being Moved to Schedule III

An official with the Department of Justice (DOJ) has officially confirmed reports that marijuana is being moved to Schedule III.

Earlier today it was reported that the Biden Administration would be rescheduling marijuana following an over eight month review by the Drug Enforcement Administration (DEA). Now, the DOJ has confirmed these reports for the first time.

“Today the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III”, says DOJ Director of Public Affairs Xochitl Hinojosa. “Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act.”

Once published in the Federal Register and given approval by the White House Office of Management and Budget, a 30-day public comment period will begin, followed by an official hearing. Unless the DEA pulls an unprecedented 180 and reverses its decision, marijuana will be rescheduled after these steps are completed.

Under current law, marijuana is classified as a Schedule I drug, rendering it illegal for all purposes. By reclassifying marijuana to Schedule III, it will effectively be legalized nationwide for prescription use. This change will also provide numerous federal protections to state-legal medical marijuana patients and businesses, which are currently unavailable under the existing classification.

The DEA’s review of marijuana’s scheduling status was prompted by the Department of Health and Human Services (HHS) requesting the change in August. HHS conducted their own year long review after an executive order from President Biden, issued in late 2022.

For a list of the 10 biggest implications of marijuana being moved to Schedule III, click here. For a list of the 10 states next in line to legalize marijuana, click here.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

 

 

More articles from The Marijuana Herald can be found below.

Study: Long-Acting Injectable CBD Shows Weeks-Long Presence in Calves, Suggesting Possible Use for Painful Farm Procedures

Study: Long-Acting Injectable CBD Shows Weeks-Long Presence in Calves, Suggesting Possible Use for Painful Farm Procedures

Bacteria From Hemp Seed Oil Shown to Combat Botrytis, Offering a New Biocontrol Tool for Cannabis Growers

Bacteria From Hemp Seed Oil Shown to Combat Botrytis, Offering a New Biocontrol Tool for Cannabis Growers

Florida Senate Bill Would Allow Qualified Patients to Grow Cannabis at Home

Florida Senate Bill Would Allow Qualified Patients to Grow Cannabis at Home

Oregon Appeal Could Set National Precedent for Adding Female Orgasmic Disorder to Medical Marijuana Programs

Oregon Appeal Could Set National Precedent for Adding Female Orgasmic Disorder to Medical Marijuana Programs

Utah Medical Cannabis Program Has Over 106,000 Active Patients, With Over $160 Million in Sales So Far in 2025

Utah Medical Cannabis Program Has Over 106,000 Active Patients, With Over $160 Million in Sales So Far in 2025

California: Coastal Sun Greenhouse Flower Products Recalled After Presence of Aspergillus niger

California: Coastal Sun Greenhouse Flower Products Recalled After Presence of Aspergillus niger

Senator Blocks Sara Carter’s Nomination for White House Drug Czar After Procedural Dispute

Senator Blocks Sara Carter’s Nomination for White House Drug Czar After Procedural Dispute

Kentucky’s First Medical Marijuana Sales Expected “Within the Next Couple of Weeks”, Says Governor

Kentucky’s First Medical Marijuana Sales Expected “Within the Next Couple of Weeks”, Says Governor

Every Cannabis Bill Filed in U.S. Congress During the 2025-2026 Session

Every Cannabis Bill Filed in U.S. Congress During the 2025-2026 Session

Massachusetts Regulators Sets December 11 Final Vote on Cannabis Consumption Sites

Massachusetts Regulators Sets December 11 Final Vote on Cannabis Consumption Sites

Numerous Signature Gathering Events Scheduled for Idaho’s Medical Cannabis Legalization Initiative

Numerous Signature Gathering Events Scheduled for Idaho’s Medical Cannabis Legalization Initiative

Study Finds Medical Cannabis Linked to Improvements in Fibromyalgia Symptoms, Including Improved Sleep, Anxiety, and Overall Wellness

Study Finds Medical Cannabis Linked to Improvements in Fibromyalgia Symptoms, Including Improved Sleep, Anxiety, and Overall Wellness

U.S. Congress: RESPECT Resolution Introduced to Advance Equity in the Marijuana Industry

U.S. Congress: RESPECT Resolution Introduced to Advance Equity in the Marijuana Industry

The Best Selling Cannabis Strains in Every Recreational State (as of December 2025)

The Best Selling Cannabis Strains in Every Recreational State (as of December 2025)

CBD May Help Stabilize Brain Chemistry in People at High Risk for Psychosis, Study Finds

CBD May Help Stabilize Brain Chemistry in People at High Risk for Psychosis, Study Finds

Massachusetts Marijuana Sales Reach $147 Million in November, $1.66 Billion in 2025, as Prices Fall to New Record Low

Massachusetts Marijuana Sales Reach $147 Million in November, $1.66 Billion in 2025, as Prices Fall to New Record Low

Chicago Council Committee Approves Ordinance to Restrict Hemp-Derived Cannabinoid Sales

Chicago Council Committee Approves Ordinance to Restrict Hemp-Derived Cannabinoid Sales

Florida’s Medical Marijuana Market Tops $1.5 Billion in Sales Through November, With Flower Leading Nearly Half of All Sales

Florida’s Medical Marijuana Market Tops $1.5 Billion in Sales Through November, With Flower Leading Nearly Half of All Sales